KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 99 filers reported holding KEROS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $63,803 | -92.4% | 1,597 | -90.9% | 0.00% | -92.9% |
| Q4 2022 | $840,944 | +32.6% | 17,475 | 0.0% | 0.01% | +27.3% |
| Q3 2022 | $634,000 | +31.5% | 17,475 | 0.0% | 0.01% | +37.5% |
| Q2 2022 | $482,000 | -92.2% | 17,475 | -84.6% | 0.01% | -91.2% |
| Q1 2022 | $6,151,000 | -23.1% | 113,119 | -17.8% | 0.09% | -30.0% |
| Q4 2021 | $7,995,000 | +46.8% | 137,636 | 0.0% | 0.13% | +46.1% |
| Q3 2021 | $5,445,000 | – | 137,636 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 292,833 | $17,134,000 | 5.65% |
| Deep Track Capital, LP | 1,300,000 | $76,063,000 | 5.37% |
| Octagon Capital Advisors LP | 340,214 | $19,906,000 | 3.87% |
| Opaleye Management Inc. | 265,750 | $15,549,000 | 3.30% |
| First Light Asset Management, LLC | 552,098 | $32,303,000 | 2.31% |
| Altium Capital Management LP | 116,000 | $6,787,000 | 1.87% |
| Nantahala Capital Management | 796,698 | $46,615,000 | 1.64% |
| Orbimed Advisors | 1,679,417 | $98,263,000 | 1.26% |
| Darwin Global Management, Ltd. | 111,500 | $6,524,000 | 1.00% |
| Parkman Healthcare Partners LLC | 69,861 | $4,088,000 | 0.90% |